cisplatin

You have access
Protective Role of Fucoidan on Cisplatin-mediated ER Stress in Renal Proximal Tubule Epithelial Cells
HYUNG JOO KIM, YEO MIN YOON, JUN HEE LEE and SANG HUN LEE

Anticancer Research October 2019, 39 (10) 5515-5524; DOI: https://doi.org/10.21873/anticanres.13744
You have access
Comparison of Pregnane X Receptor Antagonists for Enhancing the Antitumor Effect of Cisplatin
MEGUMI YASUDA, SHUICHI KISHIMOTO, MANABU AMANO and SHOJI FUKUSHIMA

Anticancer Research September 2019, 39 (9) 4749-4755; DOI: https://doi.org/10.21873/anticanres.13658
You have access
Predictive Factors for Completion of TPF Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer
KENJI NAKANO, AKIRA SETO, TORU SASAKI, WATARU SHIMBASHI, HIROFUMI FUKUSHIMA, HIROYUKI YONEKAWA, HIROKI MITANI and SHUNJI TAKAHASHI

Anticancer Research August 2019, 39 (8) 4337-4342; DOI: https://doi.org/10.21873/anticanres.13601
You have access
The Involvement of Pregnane X Receptor-regulated Pathways in the Antitumor Activity of Cisplatin
MEGUMI YASUDA, SHUICHI KISHIMOTO, MANABU AMANO and SHOJI FUKUSHIMA

Anticancer Research July 2019, 39 (7) 3601-3608; DOI: https://doi.org/10.21873/anticanres.13507
You have access
Cisplatin and Vinorelbine -Mediated Electrochemotherapeutic Approach Against Multidrug Resistant Small Cell Lung Cancer (H69AR) In Vitro
MAŁGORZATA DRĄG-ZALESIŃSKA, JOLANTA SACZKO, ANNA CHOROMAŃSKA, ANNA SZEWCZYK, NINA REMBIAŁKOWSKA, JULITA KULBACKA and ADAM RZECHONEK

Anticancer Research July 2019, 39 (7) 3711-3718; DOI: https://doi.org/10.21873/anticanres.13519
You have access
AXL Downstream Targeting Unravels Synergistic Drug Combinations in Ovarian Carcinoma Cells
DESIRÈ M. ALAMPI, EMILIO CIUSANI, NIVES CARENINI, ELISABETTA CORNA, LAURA GATTI and CRISTINA CORNO

Anticancer Research July 2019, 39 (7) 3803-3808; DOI: https://doi.org/10.21873/anticanres.13529
You have access
Protective Effect of Melatonin on Cisplatin-induced Ototoxicity in Rats
JULIANA GUSMÃO DE ARAUJO, LUCIENY SILVA MARTINS SERRA, LUCAS LAUAND, SELMA APARECIDA SOUZA KÜCKELHAUS and ANDRÉ LUIZ LOPES SAMPAIO

Anticancer Research May 2019, 39 (5) 2453-2458; DOI: https://doi.org/10.21873/anticanres.13364
You have access
Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade
DAIKO WAKITA, TOSHIKI IWAI, SUGURU HARADA, MIHO SUZUKI, KANAME YAMAMOTO and MASAMICHI SUGIMOTO

Anticancer Research April 2019, 39 (4) 1749-1760; DOI: https://doi.org/10.21873/anticanres.13281
You have access
Trastuzumab With S-1 Plus Cisplatin in HER2-positive Advanced Gastric Cancer Without Measurable Lesions: OGSG 1202
SHUNJI ENDO, YUKINORI KUROKAWA, MAKIO GAMOH, YUTAKA KIMURA, JIN MATSUYAMA, HIROKAZU TANIGUCHI, ATSUSHI TAKENO, RYOHEI KAWABATA, JUNJI KAWADA, TORU MASUZAWA, KAZUYOSHI YAMAMOTO, KOUJI KOBAYASHI, DAISUKE SAKAI, TOSHIO SHIMOKAWA and TAROH SATOH

Anticancer Research February 2019, 39 (2) 1059-1065; DOI: https://doi.org/10.21873/anticanres.13213
You have access
Metabolomics-based Discovery of Serum Biomarkers to Predict the Side-effects of Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
SHIN NISHIUMI, SEIJI FUJIGAKI, TAKASHI KOBAYASHI, TAKASHI KOJIMA, YOSHINORI ITO, HIROYUKI DAIKO, KEN KATO, HIROKAZU SHOJI, YUZO KODAMA, KAZUFUMI HONDA and MASARU YOSHIDA

Anticancer Research January 2019, 39 (1) 519-526; DOI: https://doi.org/10.21873/anticanres.13143

Main menu

User menu

Search

cisplatin

Pages